Concepts (204)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bambusa | 5 | 2012 | 10 | 1.900 |
Why?
|
| Plant Extracts | 6 | 2012 | 250 | 1.890 |
Why?
|
| Palmitic Acid | 5 | 2016 | 24 | 1.340 |
Why?
|
| Mitochondria | 3 | 2020 | 454 | 1.290 |
Why?
|
| Chemokine CCL2 | 3 | 2012 | 82 | 1.190 |
Why?
|
| Glutathione | 6 | 2014 | 160 | 0.970 |
Why?
|
| Oxidative Stress | 10 | 2015 | 874 | 0.930 |
Why?
|
| Poaceae | 2 | 2012 | 11 | 0.830 |
Why?
|
| Phytotherapy | 3 | 2012 | 62 | 0.830 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2020 | 224 | 0.800 |
Why?
|
| Dietary Supplements | 2 | 2012 | 196 | 0.730 |
Why?
|
| Antioxidants | 6 | 2014 | 386 | 0.720 |
Why?
|
| Cholesterol | 1 | 2020 | 194 | 0.680 |
Why?
|
| Obesity | 5 | 2018 | 965 | 0.660 |
Why?
|
| Methamphetamine | 3 | 2015 | 155 | 0.650 |
Why?
|
| Cognition | 2 | 2020 | 373 | 0.640 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2016 | 592 | 0.570 |
Why?
|
| Drugs, Chinese Herbal | 2 | 2016 | 20 | 0.530 |
Why?
|
| Transcription Factor AP-1 | 2 | 2012 | 33 | 0.510 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2015 | 63 | 0.490 |
Why?
|
| Thalamus | 1 | 2014 | 29 | 0.490 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 120 | 0.440 |
Why?
|
| Animals | 21 | 2018 | 14307 | 0.430 |
Why?
|
| Anti-Anxiety Agents | 1 | 2012 | 14 | 0.420 |
Why?
|
| NF-kappa B | 2 | 2012 | 306 | 0.420 |
Why?
|
| Mice | 13 | 2018 | 5668 | 0.420 |
Why?
|
| Diabetes Complications | 1 | 2012 | 91 | 0.410 |
Why?
|
| HIV-1 | 2 | 2014 | 678 | 0.400 |
Why?
|
| Depression | 2 | 2015 | 664 | 0.400 |
Why?
|
| Cell Differentiation | 1 | 2014 | 562 | 0.390 |
Why?
|
| Liver | 2 | 2010 | 447 | 0.390 |
Why?
|
| Superoxides | 2 | 2007 | 51 | 0.380 |
Why?
|
| Interleukin-6 | 1 | 2011 | 140 | 0.380 |
Why?
|
| Cardiovascular Diseases | 2 | 2016 | 628 | 0.370 |
Why?
|
| Cell Line | 8 | 2018 | 1289 | 0.350 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2008 | 28 | 0.340 |
Why?
|
| Selenoproteins | 2 | 2007 | 151 | 0.330 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2008 | 70 | 0.320 |
Why?
|
| Metabolic Detoxication, Phase II | 1 | 2007 | 4 | 0.310 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2007 | 12 | 0.310 |
Why?
|
| Male | 12 | 2020 | 18870 | 0.290 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 160 | 0.290 |
Why?
|
| Pilot Projects | 2 | 2020 | 628 | 0.290 |
Why?
|
| Signal Transduction | 2 | 2012 | 1802 | 0.280 |
Why?
|
| Selenium | 1 | 2007 | 144 | 0.260 |
Why?
|
| Fatty Acids, Nonesterified | 3 | 2016 | 39 | 0.260 |
Why?
|
| Anxiety | 1 | 2012 | 705 | 0.260 |
Why?
|
| Neurons | 4 | 2014 | 1130 | 0.250 |
Why?
|
| DNA-Binding Proteins | 2 | 2007 | 522 | 0.250 |
Why?
|
| HIV Infections | 2 | 2015 | 2207 | 0.240 |
Why?
|
| RNA, Messenger | 4 | 2012 | 1152 | 0.220 |
Why?
|
| Flavonoids | 3 | 2013 | 78 | 0.220 |
Why?
|
| Bile Acids and Salts | 2 | 2018 | 31 | 0.200 |
Why?
|
| Cell Survival | 4 | 2013 | 818 | 0.200 |
Why?
|
| Humans | 15 | 2020 | 34853 | 0.200 |
Why?
|
| Plant Leaves | 2 | 2012 | 110 | 0.190 |
Why?
|
| Protein Transport | 2 | 2012 | 286 | 0.190 |
Why?
|
| Lipase | 1 | 2020 | 16 | 0.190 |
Why?
|
| Stearic Acids | 2 | 2016 | 5 | 0.190 |
Why?
|
| Female | 8 | 2020 | 19873 | 0.190 |
Why?
|
| Sulfotransferases | 2 | 2010 | 7 | 0.180 |
Why?
|
| Cell Nucleus | 2 | 2012 | 351 | 0.180 |
Why?
|
| Rats | 5 | 2016 | 3261 | 0.180 |
Why?
|
| Metabolomics | 2 | 2018 | 76 | 0.180 |
Why?
|
| Liver Failure, Acute | 1 | 2018 | 4 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 3 | 2018 | 1530 | 0.170 |
Why?
|
| Ammonia | 1 | 2018 | 17 | 0.170 |
Why?
|
| Disease Models, Animal | 3 | 2018 | 1300 | 0.170 |
Why?
|
| Hepatic Encephalopathy | 1 | 2018 | 9 | 0.170 |
Why?
|
| Young Adult | 2 | 2020 | 4012 | 0.170 |
Why?
|
| Glutathione Transferase | 2 | 2010 | 83 | 0.170 |
Why?
|
| Oxidation-Reduction | 2 | 2012 | 407 | 0.160 |
Why?
|
| Metabolome | 1 | 2018 | 47 | 0.160 |
Why?
|
| Adult | 5 | 2020 | 11034 | 0.150 |
Why?
|
| Rats, Transgenic | 2 | 2014 | 27 | 0.150 |
Why?
|
| Hepatitis B, Chronic | 1 | 2017 | 11 | 0.150 |
Why?
|
| Lysophosphatidylcholines | 1 | 2017 | 19 | 0.150 |
Why?
|
| Feces | 1 | 2017 | 110 | 0.150 |
Why?
|
| Brain | 2 | 2016 | 1268 | 0.150 |
Why?
|
| Food | 1 | 2018 | 95 | 0.150 |
Why?
|
| Gastric Bypass | 1 | 2016 | 14 | 0.150 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1056 | 0.150 |
Why?
|
| Adrenal Insufficiency | 1 | 2016 | 1 | 0.150 |
Why?
|
| Liver Cirrhosis | 1 | 2017 | 51 | 0.150 |
Why?
|
| Protective Agents | 2 | 2016 | 22 | 0.150 |
Why?
|
| Gene Expression Regulation | 2 | 2012 | 968 | 0.140 |
Why?
|
| Carcinoma | 1 | 2017 | 94 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2013 | 984 | 0.140 |
Why?
|
| Buthionine Sulfoximine | 1 | 2005 | 10 | 0.130 |
Why?
|
| Hippocampus | 3 | 2007 | 546 | 0.130 |
Why?
|
| Longevity | 1 | 2016 | 143 | 0.120 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 195 | 0.120 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2015 | 243 | 0.120 |
Why?
|
| Dementia | 1 | 2015 | 133 | 0.120 |
Why?
|
| Milk | 1 | 2013 | 48 | 0.120 |
Why?
|
| Milk, Human | 1 | 2013 | 29 | 0.120 |
Why?
|
| Sodium Selenite | 1 | 2013 | 4 | 0.120 |
Why?
|
| Glutathione Peroxidase | 1 | 2013 | 109 | 0.110 |
Why?
|
| Drug Therapy | 1 | 2012 | 18 | 0.110 |
Why?
|
| Plant Stems | 1 | 2012 | 8 | 0.110 |
Why?
|
| Receptors, Nicotinic | 1 | 2013 | 91 | 0.110 |
Why?
|
| Apoptosis | 2 | 2011 | 1317 | 0.110 |
Why?
|
| Mice, Inbred Strains | 1 | 2012 | 117 | 0.110 |
Why?
|
| Middle Aged | 5 | 2018 | 9642 | 0.110 |
Why?
|
| Antidepressive Agents | 1 | 2012 | 53 | 0.100 |
Why?
|
| Exploratory Behavior | 1 | 2012 | 72 | 0.100 |
Why?
|
| Homeostasis | 1 | 2013 | 172 | 0.100 |
Why?
|
| 3T3-L1 Cells | 1 | 2011 | 14 | 0.100 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 465 | 0.100 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2011 | 13 | 0.100 |
Why?
|
| Central Nervous System Stimulants | 1 | 2013 | 165 | 0.100 |
Why?
|
| Transcription Factor RelA | 1 | 2011 | 37 | 0.100 |
Why?
|
| Intra-Abdominal Fat | 1 | 2011 | 39 | 0.100 |
Why?
|
| Culture Media | 1 | 2011 | 84 | 0.100 |
Why?
|
| Organ Size | 1 | 2011 | 148 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2011 | 74 | 0.100 |
Why?
|
| Peptide Fragments | 1 | 2013 | 298 | 0.100 |
Why?
|
| Adipocytes | 1 | 2011 | 54 | 0.100 |
Why?
|
| Mice, Obese | 1 | 2010 | 37 | 0.100 |
Why?
|
| Biotransformation | 1 | 2010 | 65 | 0.100 |
Why?
|
| Glucuronosyltransferase | 1 | 2010 | 25 | 0.100 |
Why?
|
| Random Allocation | 1 | 2010 | 139 | 0.090 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2010 | 82 | 0.090 |
Why?
|
| Calcium | 1 | 2013 | 445 | 0.090 |
Why?
|
| Aging | 1 | 2015 | 639 | 0.090 |
Why?
|
| Behavior, Animal | 1 | 2012 | 304 | 0.090 |
Why?
|
| Energy Intake | 1 | 2010 | 160 | 0.090 |
Why?
|
| Models, Biological | 1 | 2013 | 642 | 0.090 |
Why?
|
| Inflammation | 1 | 2014 | 577 | 0.090 |
Why?
|
| Overweight | 1 | 2012 | 233 | 0.090 |
Why?
|
| Diet | 2 | 2016 | 747 | 0.080 |
Why?
|
| Body Weight | 1 | 2010 | 404 | 0.080 |
Why?
|
| Vero Cells | 1 | 2008 | 90 | 0.080 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 550 | 0.080 |
Why?
|
| Time Factors | 1 | 2012 | 1681 | 0.080 |
Why?
|
| Malonates | 1 | 2007 | 2 | 0.080 |
Why?
|
| Polyenes | 1 | 2007 | 4 | 0.080 |
Why?
|
| Antimycin A | 1 | 2007 | 5 | 0.080 |
Why?
|
| Electron Transport Complex II | 1 | 2007 | 7 | 0.080 |
Why?
|
| Electron Transport Complex III | 1 | 2007 | 12 | 0.080 |
Why?
|
| High Mobility Group Proteins | 1 | 2007 | 4 | 0.080 |
Why?
|
| Rotenone | 1 | 2007 | 18 | 0.080 |
Why?
|
| Apoferritins | 1 | 2007 | 5 | 0.080 |
Why?
|
| Electron Transport Complex I | 1 | 2007 | 20 | 0.080 |
Why?
|
| Flow Cytometry | 1 | 2008 | 392 | 0.070 |
Why?
|
| Ultraviolet Rays | 1 | 2007 | 116 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 245 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2008 | 834 | 0.070 |
Why?
|
| Alzheimer Disease | 1 | 2013 | 881 | 0.070 |
Why?
|
| Binding Sites | 1 | 2007 | 597 | 0.070 |
Why?
|
| Reactive Oxygen Species | 3 | 2013 | 416 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2007 | 490 | 0.060 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 1124 | 0.060 |
Why?
|
| Gene Expression | 1 | 2007 | 639 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2008 | 1534 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 756 | 0.050 |
Why?
|
| Lipid Metabolism | 1 | 2018 | 109 | 0.040 |
Why?
|
| Acetyltransferases | 1 | 2016 | 26 | 0.040 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 2016 | 4 | 0.040 |
Why?
|
| Oleic Acid | 1 | 2016 | 19 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2013 | 2128 | 0.040 |
Why?
|
| Arachidonic Acid | 1 | 2016 | 32 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2016 | 91 | 0.040 |
Why?
|
| Least-Squares Analysis | 1 | 2016 | 42 | 0.040 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2016 | 11 | 0.040 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2016 | 75 | 0.040 |
Why?
|
| ROC Curve | 1 | 2016 | 138 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2016 | 80 | 0.030 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2016 | 36 | 0.030 |
Why?
|
| China | 1 | 2016 | 178 | 0.030 |
Why?
|
| Hydrocortisone | 1 | 2016 | 72 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2016 | 202 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2016 | 188 | 0.030 |
Why?
|
| Amino Acids | 1 | 2016 | 139 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2016 | 140 | 0.030 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2016 | 103 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2016 | 255 | 0.030 |
Why?
|
| Lipid Peroxidation | 1 | 2005 | 131 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2016 | 406 | 0.030 |
Why?
|
| Infant Formula | 1 | 2013 | 13 | 0.030 |
Why?
|
| Electrochemical Techniques | 1 | 2013 | 22 | 0.030 |
Why?
|
| Spectrophotometry | 1 | 2013 | 71 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2013 | 32 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2013 | 34 | 0.030 |
Why?
|
| Logistic Models | 1 | 2016 | 894 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 841 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 2013 | 228 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2016 | 775 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2013 | 420 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2013 | 871 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2016 | 1961 | 0.020 |
Why?
|
| Homocysteine | 1 | 2007 | 18 | 0.020 |
Why?
|
| Radiation Tolerance | 1 | 2007 | 12 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2007 | 40 | 0.020 |
Why?
|
| DNA Primers | 1 | 2007 | 269 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 298 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2007 | 286 | 0.020 |
Why?
|
| Cell Death | 1 | 2007 | 260 | 0.020 |
Why?
|
| Neurodegenerative Diseases | 1 | 2007 | 119 | 0.020 |
Why?
|
| Transfection | 1 | 2007 | 496 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 605 | 0.020 |
Why?
|
| Aged | 1 | 2016 | 6448 | 0.020 |
Why?
|
| Base Sequence | 1 | 2007 | 932 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 600 | 0.010 |
Why?
|